Table 1. Details of the clinicopathological feature-based classification of BLCA and HNSC samples analyzed in the current study.

Sr. No.	Clinicopathological feature	Sample count	Total sample count	Sample count with missing information	Total final sample count undertaken in analysis
Clinicopathological feature-based classification of BLCA samples
1	Cancer stage distribution		408
	Stage 1	02
	Stage 2	129		08	400
	Stage 3	137
	Stage 4	132
2	Geographical distribution
	Caucasian	320
	African-American	22		22	386
	Asian	44
3	Gender distribution
	Male	297		06	402
	Female	105
4	Age distribution
	21–40 years	02
	41–60 years	105		06	402
	61–80 years	251
	81–100 years	44
Clinicopathological feature-based classification of HNSC samples
1	Cancer stage distribution		520
	Stage 1	27
	Stage 2	71		77	443
	Stage 3	81
	Stage 4	264
2	Geographical distribution
	Caucasian	444
	African-American	47		18	502
	Asian	11
3	Gender distribution
	Male	383		01	519
	Female	136
4	Age distribution
	21–40 years	20
	41–60 years	236		03	517
	61–80 years	237
	81–100 years	24